跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

C-045

Supelco

大麻二酚标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

别名:

CBD

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C21H30O2
CAS号:
13956-29-1
分子量:
314.46
EC 号:
200-659-6
MDL编号:
MFCD00869597
UNSPSC代码:
41116107
PubChem化学物质编号:
329774791
NACRES:
NA.24

等级

certified reference material

质量水平

300

表单

liquid

特点

SNAP-N-SPIKE®, SNAP-N-SHOOT®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

1.0 mg/mL in methanol

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

cannabis testing
cannabis testing

包装形式

single component solution

储存温度

−20°C

SMILES字符串

CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(C)=C)c(O)c1

InChI

1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1

InChI key

QHMBSVQNZZTUGM-ZWKOTPCHSA-N

基因信息

human ... CNR1(1268)

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

该认证加标溶液® 适用于通过 HPLC、GC/MS 或 LC-MS/MS 法进行大麻二酚测定，从而用于法医分析、临床毒理学、尿液药物测试和大麻效力或杂质分析测试等应用。

大麻二酚（CBD）是大麻科植物中发现的重要大麻素之一，以其非精神活性特性而闻名。它在光或热的作用下由前体大麻二酚酸脱羧形成。它具有多种治疗特性，如抗氧化、抗炎、抗菌、神经保护、抗焦虑和抗惊厥作用。

应用

该认证标准物质（CRM）还可作如下用途：
  • 使用反相高效液相色谱（RP-HPLC）结合二极管阵列检测器（DAD）测定油基质中放入 4 种大麻素
  • 开发和验证基于液相色谱-串联质谱（LC-MS/MS）的技术，用于测量大鼠高剂量大麻二酚全血样品中的大麻二酚、∆9-四氢大麻酚及其代谢物
  • 使用等密度 RP-HPLC 结合 UV 检测法同时测定不同大麻油产品中的大麻二酚和四氢大麻酚
  • 通过液-液萃取（LLE）后跟气相色谱-质谱法对头发样品中的 Δ9-四氢大麻酚、大麻酚和大麻二酚进行多重分析
  • 超声辅助提取三种不同商业外用产品中的大麻二酚，并以 GC-MS 法测定

特点和优势

  • 完全符合 ISO/IEC 17025 和 ISO 17034 认证
  • 附综合分析证书（CoA），包括稳定性、均匀性、浓度准确性、不确定性和可追溯性数据
  • 通过实时稳定性研究严格测试，以确保准确性和保质期
  • 使用合格的精密天平进行重量准备，以确保最小不确定性
  • 氩气环境下火焰密封，装入安瓿以便长期保存
  • 提供方便的 DEA 豁免格式，以提高实验室效率

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

C-046

大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-084

Cannabidiol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-115

Cannabinol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

−-Δ9-四氢大麻酚-D3标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-011

−-Δ9-四氢大麻酚-D3标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-032

(−)-Δ8-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-033

exo-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-047

(±)-Δ9-四氢大麻酚标准液 溶液, 100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

C-150

Cannabichromenic Acid (CBCA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-153

大麻酚酸（CBNA） 溶液, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

T-111

四氢次大麻酚酸（THCVA） 溶液, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-171

大麻环酸(CBLA)标准液 溶液, 0.5 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-180

7-Hydroxy cannabidiol (7-OH-CBD) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-217

Hemp Compliance Mix solution, certified reference material, ampule of 1 mL, Cerilliant®

C-219

Cannabinoid Mixture (Neutrals) - 8 Component solution, 500 μg/mL in methanol (each analyte), certified reference material, ampule of 1 mL, Cerilliant®

T-151

THC-O-Acetate solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-181

7-Carboxy cannabidiol (7-COOH-CBD) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-220

Cannabinoid Mixture - 3 Component solution, 1 mg/mL in methanol ((each analyte)), certified reference material, ampule of 1 mL, Cerilliant®

C-218

Cannabinoid Mixture (Acids) - 6 Component solution, 500 μg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile,each analyte), certified reference material, ampule of 1 mL, Cerilliant®

C-223

7-Hydroxy cannabidiol-D3 (7-OH-CBD-D3) solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-224

7-Carboxy cannabidiol-D3 (7-COOH-CBD-D3) solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

T-112

11-Nor-9-carboxy-delta9-THCV solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-244

Cannabichromenic Acid (CBCA) solution, 1 mg/mL (1% DIPEA and 0.05% Ascorbic acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-240

Cannabidiphorol (CBDP) solution, 1 mg/mL (1% DIPEA and 0.05% Ascorbic Acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-254

6-Hydroxy cannabidiol (6-OH-CBD) solution, 1 mg/mL (Degassed Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-228

Cannabidiol Hydroxyquinone (HU-331), certified reference material, vial of 5 mg, Cerilliant®

C-246

Cannabielsoin (CBE) solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

H-158

HU-308 solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

C-264

大麻环酸(CBLA)标准液 溶液, 0.5 mg/mL (0.1% DIPEA, 0.05 Ascorbic Acid in Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

T-182

THC-O-Acetate solution, 1 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

C-255

6-Hydroxy cannabidiol-D3 (6-OH-CBD-D3) solution, 100 μg/mL (Degassed Acetonitrile), certified reference material, ampule of 1 mL, Cerilliant®

C-238

Cannabidiol-O-beta-D-glucuronide sodium salt solution, 100 μg/mL in methanol (as free carboxylate), certified reference material, ampule of 1 mL, Cerilliant®

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number

抱歉，我们目前尚未线上提供该产品的COA。

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

R B Laprairie et al.
British journal of pharmacology, 172(20), 4790-4805 (2015-07-29)
Cannabidiol has been reported to act as an antagonist at cannabinoid CB1 receptors. We hypothesized that cannabidiol would inhibit cannabinoid agonist activity through negative allosteric modulation of CB1 receptors. Internalization of CB1 receptors, arrestin2 recruitment, and PLCβ3 and ERK1/2 phosphorylation
Raymond J M Niesink et al.
Addiction (Abingdon, England), 110(12), 1941-1950 (2015-08-04)
Between 2000 and 2005 the average percentage of Δ(9) -tetrahydrocannabinol (THC) in marijuana as sold in Dutch coffeeshops has increased substantially; the potency of domestic products (Nederwiet and Nederhasj) has particularly increased. In contrast with imported marijuana, Nederwiet hardly contained
Marcos Hortes N Chagas et al.
Journal of psychopharmacology (Oxford, England), 27(3), 312-316 (2013-01-25)
Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle. The objective of this paper is to assess the effects on sleep of acute systemic administration
Javier Fernández-Ruiz et al.
British journal of clinical pharmacology, 75(2), 323-333 (2012-05-26)
Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders exerted through molecular mechanisms that are yet to be completely identified. CBD acts in some experimental models as an anti-inflammatory, anticonvulsant, anti-oxidant, anti-emetic, anxiolytic and antipsychotic agent, and is
Amir Englund et al.
Journal of psychopharmacology (Oxford, England), 27(1), 19-27 (2012-10-09)
Community-based studies suggest that cannabis products that are high in Δ⁹-tetrahydrocannabinol (THC) but low in cannabidiol (CBD) are particularly hazardous for mental health. Laboratory-based studies are ideal for clarifying this issue because THC and CBD can be administered in pure
查看所有相关文献

商品

Vitamin E Acetate Analysis in Vaping Solution

HPLC separates vitamin E acetate, THC, and CBD in vape products, providing accurate analysis of commercially available vape liquids.

Cannabinoid CRMs: Testing Accuracy & Traceability

ISO-certified cannabinoid CRMs, THC and THCA, available as single components or mixes, for accurate potency testing.

Cannabinoids Analysis Workflow with Chromolith® Column

HPLC-DAD workflow analyzes 14 cannabinoids in hemp extracts in 10 minutes using Chromolith columns for robust performance.

Optimizing for High Throughput Analysis of Cannabinoids in a Variety of Matrices Using Ascentis® Express C18 Column

A complete workflow for the HPLC separation of 17 cannabinoids in different cannabis products using Ascentis® Express C18 Column in a shorter run time with retention time stability. Learn more here.

查看所有结果

实验方案

Analysis of Active Cannabis Compounds

HPLC-UV analysis of active compounds in marijuana-infused edibles for potency testing; complex matrix requires precise methods.

Analysis of Active Cannabis Compounds (Cannabinoids) in Edible Food Products: Gummy Bears and Brownies

Rapid potency testing of marijuana-infused edibles using LC/MS on a biphenyl stationary phase detected eleven cannabinoids.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门